Harbour, J. W., Reichstein, D. A., Angi, M., Sagoo, M. S., O'day, R., Butler, M. O., Shaw, H. M., McKean, M., Fog, L. S., Chao, S. T., Waldron, J. N., Chao, M. M., Kwei, L., Sachdev, J. C., Beaupre, D. M., Shields, C. L. (2026). Neoadjuvant darovasertib in uveal melanoma patients undergoing primary local therapy (OptimUM-10): Phase 3 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9608